Early Stage Prostate Cancer Results Favorable for Radiation Treatment
Published : 2009-03-17 - Updated : 2016-05-25
Author : American Society for Therapeutic Radiology and Oncology
Synopsis* : Results show a shortened course of radiation therapy for prostate cancer provides good PSA response for early-stage prostate cancer.
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments.
Study authors caution that further follow-up will be necessary to establish that SBRT is as effective in the long term as other proven treatments.
Radiation therapy is an effective way to treat localized prostate cancer.
Proven successful treatments include brachytherapy (seed implants) where radiation sources are placed directly into the prostate and external beam radiation therapy where doctors give small daily doses of radiation to the prostate, five days a week, for eight weeks to give enough radiation to kill the cancer cells while sparing nearby healthy tissue.
External beam radiation therapy can be a very effective and minimally invasive treatment.
However, the length of treatment can be burdensome for some patients, particularly those who live very far from a treatment facility. Doctors have been investigating ways to shorten the course of the treatment through a technique called stereotactic body radiation therapy, where radiation oncologists give a higher dose of radiation every day for five days. Growing biologic evidence also suggests that delivering radiotherapy in this fashion might be more effective for prostate cancer than conventionally protracted courses.
In this study, researchers from Stanford University treated 41 men with low-risk prostate cancer with SBRT.
After a median follow-up of 33 months, no man in the study has seen his cancer return. Men in the study reported side effects, including urinary and rectal problems that were no better or worse than with other prostate cancer radiation treatments.
"There is great enthusiasm in reducing the length of treatment for prostate cancer while also possibly improving its effectiveness, and these early results are very promising for men with early-stage prostate cancer," Christopher King, Ph.D., M.D., an associate professor of radiation oncology at Stanford University School of Medicine in Stanford, Calif., said. "However, it can often take as long as 10 years to see late side effects and recurrences, so we will have to monitor these men closely and cautiously pursue these treatments further before we can confidently say that SBRT is as good as other proven prostate cancer treatments, like external beam radiation therapy, brachytherapy or surgery."
ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit www.rtanswers.org. To learn more about ASTRO, visit www.astro.org.
You're reading Disabled World. Be sure to check out our homepage for further informative disability news, reviews, disability sports events, exclusive stories and how-tos. You can also find us on Twitter, Facebook, and LinkedIn.
Related Prostate Cancer Documents
- 1 - Prostate MRI Reveals More Treatable Cancers and Reduces Overdiagnosis : PRECISION trial reveals using MRI to target prostate biopsies leads to more of the harmful prostate cancers, and fewer harmless cancers being diagnosed.
- 2 - A More Complete Mediterranean Diet May Protect Against Aggressive Prostate Cancer : New study finds that a high intake of fruits, vegetables, and whole grains might not be enough.
- 3 - Digital Rectal Exam Vs. PSA Test For Prostate Cancer : Is the digital rectal exam (DRE) as a screening tool for prostate cancer as good as the prostate specific antigen (PSA) test.
- 4 - First Prostate Cancer Patients Treated with HIFU Technology : Cordell Nwokeji, MD and Don Berardinucci, MD perform first Sonablate HIFU treatments in Houston, Texas at Houston Metro Urology in partnership with HIFU Prostate Services.
- 5 - Male Prostate Exam: PSA, DRE and PVR Tests : Prostate-related diseases such as prostatitis, BPH or elevated PSA can occur for a number of reasons, this article looks at the types of prostate examination including PSA, DRE and PVR tests.
*Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information. Please report outdated or inaccurate information to us.
Journal: Disabled World. Language: English (U.S.). Author: American Society for Therapeutic Radiology and Oncology. Electronic Publication Date: 2009-03-17 - Revised: 2016-05-25. Title: Early Stage Prostate Cancer Results Favorable for Radiation Treatment, Source: <a href=https://www.disabled-world.com/health/cancer/prostate/prostate-cancer-radiation.php>Early Stage Prostate Cancer Results Favorable for Radiation Treatment</a>. Retrieved 2021-05-07, from https://www.disabled-world.com/health/cancer/prostate/prostate-cancer-radiation.php - Reference: DW#132-1113.